Market Cap

Conversion Labs, Inc. Market Capitalization:

€61.43 Billion

EUR as of Jan. 1, 2024

US$67.85 Billion

business Conversion Labs, Inc. Company Profile

Conversion Labs, Inc. Main Stock Listing

NASDAQ: CVLB

Market Capitalization History of Conversion Labs, Inc.

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Pharmaceutical Retailers
Company Market Cap (USD)
Walgreens Boots Alliance, Inc. $22.04 B
Raia Drogasil SA $10.34 B
Matsumotokiyoshi Holdings Co. Ltd $7.60 B
Alibaba Health Information Technology Ltd $6.71 B
Yifeng Pharmacy Chain Co. Ltd $5.89 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $586.39 B
UnitedHealth Group $504.47 B
Novo Nordisk $461.52 B
Johnson & Johnson $387.50 B
Merck $296.51 B

Yearly evolution of Conversion Labs, Inc. market cap

Date Market Cap YoY Change
Jan. 1, 2024 €61.43 B -20.41%
Jan. 1, 2023 €77.19 B 22.43%
Jan. 1, 2022 €63.05 B 0.74%
Jan. 1, 2021 €62.58 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +284.14%

$10,000 in April 2023 would now be $38,414 by following this algorithm daily at market close.

Boost your stocks returns with Disfold AI... Now!

Try Disfold AI for FREE

Conversion Labs, Inc. Categories

United States languages Healthcare languages Pharmaceutical Retailers
United States Healthcare United States Pharmaceutical Retailers

Stocks & Indices

Conversion Labs, Inc. has the following listings and related stock indices.


Stock: NASDAQ: CVLB

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.